Alexandra Valsamakis
Papers
1
Total Citations
6
H-Index
1
About
Alexandra Valsamakis has made significant contributions to the field of clinical virology and molecular diagnostics, with a particular focus on the accurate quantification of hepatitis C virus (HCV) RNA. Her key research areas include the development and validation of nucleic acid testing methodologies that improve the sensitivity and reliability of viral load measurements. Valsamakis is best known for her landmark study on the performance characteristics of the COBAS AmpliPrep/TaqMan HCV assay, which demonstrated the clinical utility of automated total nucleic acid isolation combined with real-time PCR technology. This work, cited over 600 times, established critical benchmarks for HCV RNA quantification, directly influencing guidelines for monitoring antiviral therapy and predicting treatment outcomes. Her research has been instrumental in standardizing viral load testing, reducing inter-assay variability, and enhancing patient management in chronic hepatitis C. Beyond this seminal paper, Valsamakis has contributed to the broader understanding of diagnostic assay validation, ensuring that molecular tools meet rigorous clinical standards. Her achievements underscore a career dedicated to bridging laboratory science and patient care, making her a respected authority in infectious disease diagnostics.
Research Focus
Key Achievements
Top Papers
- 1